John J. Turchi

Also affiliated with University of Indianapolis, NĒRx BioSciences (United States), Indiana Cancer Consortium, Indiana University School of Medicine, Indiana University – Purdue University Indianapolis

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 19 papers. Top paper: “Discovery and development of novel DNA-PK inhibitors by targeting the unique Ku–DNA interaction”.

Discovery and development of novel DNA-PK inhibitors by targeting the unique Ku–DNA interaction

Nucleic Acids Research(2020)10.1093/nar/gkaa934

N/A

0DataRank · unranked

48 citations

Pamela S. VanderVere-Carozza, Katherine S. Pawelczak, Pamela L Mendoza-Munoz, Tyler L. Vernon, Leslyn A. Hanakahi +8 more

Discovery and Development of Novel DNA-PK Inhibitors by Targeting the unique Ku-DNA Interaction

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.08.24.261875

N/A

0DataRank · unranked

4 citations

Pamela S. VanderVere-Carozza, Katherine S. Pawelczak, Tyler L. Vernon, Leslyn A. Hanakahi, Matthew Summerlin +7 more

Chemical exhaustion of RPA in cancer treatment

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.11.30.404640

N/A

0DataRank · unranked

4 citations

Katherine S. Pawelczak, Navnath S. Gavande, Shadia I. Jalal, Karen E. Pollok, Elmira Ekinci +4 more

OB-Folds and Genome Maintenance: Targeting Protein–DNA Interactions for Cancer Therapy

Cancers(2021)10.3390/cancers13133346

N/A

0DataRank · unranked

13 citations

Sofia Vaides, Pamela S. VanderVere-Carozza, Katherine S. Pawelczak, Jason A. Stewart, John J. Turchi +1 more

Recent Advances in the Development of Non-PIKKs Targeting Small Molecule Inhibitors of DNA Double-Strand Break Repair

Frontiers in Oncology(2022)10.3389/fonc.2022.850883

N/A

0DataRank · unranked

24 citations

Amirreza Samarbakhsh, Athira Pillai, Pamela S. VanderVere-Carozza, Hariprasad Aruri, Deepti S. Pandey +4 more

In Vivo Targeting Replication Protein A for Cancer Therapy

Frontiers in Oncology(2022)10.3389/fonc.2022.826655

N/A

0DataRank · unranked

23 citations

Navnath S. Gavande, Shadia I. Jalal, Karen E. Pollok, Elmira Ekinci, Joshua Heyza +5 more

Characterization and initial demonstration of in vivo efficacy of a novel heat-activated metalloenediyne anti-cancer agent

International Journal of Hyperthermia(2022)10.1080/02656736.2021.2024280

N/A

0DataRank · unranked

2 citations

Erin M. Metzger, Mark W. Dewhirst, Karen E. Pollok, John J. Turchi, I. Caroline Le Poole +6 more

Editorial: Targeting DNA repair and the DNA damage response: Beyond the standard PI3 kinase-like kinases

Frontiers in Oncology(2022)10.3389/fonc.2022.1023500

N/A

0DataRank · unranked

1 citations

Katherine S. Pawelczak, Michael Weinfeld, Peter J. McHugh, John J. Turchi

ATR inhibition overcomes platinum tolerance associated with ERCC1- and p53-deficiency by inducing replication catastrophe

NAR Cancer(2023)10.1093/narcan/zcac045

N/A

0DataRank · unranked

11 citations

Elmira Ekinci, Jacob Lindquist, Wen Lei, Christopher K. Yunker, Vilvanathan Vinothkumar +13 more

Ku–DNA binding inhibitors modulate the DNA damage response in response to DNA double-strand breaks

NAR Cancer(2023)10.1093/narcan/zcad003

N/A

0DataRank · unranked

8 citations

Navnath S. Gavande, Pamela S. VanderVere-Carozza, Katherine S. Pawelczak, Joseph R. Dynlacht, Joy Garrett +2 more

The effect of replication protein A inhibition and post-translational modification on ATR kinase signaling

Scientific Reports(2024)10.1038/s41598-024-70589-y

N/A

0DataRank · unranked

4 citations

Greg G. Oakley, Lindsey D. Mayo, Lata Balakrishnan, John J. Turchi, Matthew R. Jordan

Impact of Optimized Ku–DNA Binding Inhibitors on the Cellular and In Vivo DNA Damage Response

Cancers(2024)10.3390/cancers16193286

N/A

0DataRank · unranked

3 citations

Narva Deshwar Kushwaha, Dineshsinha Chauhan, Karim Ben Ali Gacem, Joy Garrett, Joseph R. Dynlacht +4 more

Biochemical Impact of p300-Mediated Acetylation of Replication Protein A: Implications for DNA Metabolic Pathway Choice

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.04.22.590612

N/A

0DataRank · unranked

1 citations

Sneha Surendran, Olivia Kay Howald, Athena Kantartzis-Petrides, Matthew R. Jordan, Diana Ainembabazi +4 more

Targeting DNA damage sensors for cancer therapy

DNA repair(2025)10.1016/j.dnarep.2025.103841

N/A

0DataRank · unranked

3 citations

Pamela L. Mendoza-Munoz, Katherine S. Pawelczak, John J. Turchi, Matthew R. Jordan

Biochemical impact of p300-mediated acetylation of replication protein A: Implications for DNA metabolic pathway choice

Journal of Biological Chemistry(2025)10.1016/j.jbc.2025.110250

N/A

0DataRank · unranked

1 citations

Sneha Surendran, Tripthi Battapadi, Pamela S. VanderVere-Carozza, Olivia Kay Howald, Athena Kantartzis-Petrides +6 more

Chemical inhibition of RPA gap protection sensitizes BRCA1-deficient cancers to PARP inhibition

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.04.09.647957

N/A

0DataRank · unranked

0 citations

Matthew R. Jordan, Joy Garrett, Karen E. Pollok, Hilary D. Hinshaw, Xierzhatijiang Sulaiman +5 more

Potentiation of EGFR mutant lung cancer treatment targeting replication stress

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.04.18.649510

N/A

0DataRank · unranked

0 citations

John J. Turchi, Shadia I. Jalal, Reshma Bhowmick

Structure-Based Design and Development of 2-Oxindole Derivatives as Next Generation Ku-DNA Binding Inhibitors (Ku-DBi’s) for Cancer Therapy.

ChemRxiv(2025)10.26434/chemrxiv-2025-bp68g

N/A

0DataRank · unranked

0 citations

Dineshsinha Chauhan, Pamela L. Mendoza-Munoz, Joseph Engel, Hariprasad Aruri, Ladislau C. Kovari +3 more

Design, synthesis, and structure–activity relationship studies of 4-substituted phenylpyrazolidinone derivatives as potent Ku70/80 targeted DNA-PK inhibitors

RSC Medicinal Chemistry(2025)10.1039/d5md00263j

N/A

0DataRank · unranked

0 citations

Pamela S. VanderVere-Carozza, Tyler L. Vernon, Pamela L. Mendoza-Munoz, Jitender Dev Gaddameedi, Karim Ben Ali Gacem +5 more